BridgeMD
New treatment option for IBS - Irritable Bowel Syndrome
Official title Sucrase-Isomaltase (SI) Genes and Meal Load
ClinicalTrials.gov ID: NCT07309601
What this study is testing
- What it's testing
- The goal of this interventional study is to examine whether those patients with irritable bowel syndrome (IBS) and a reduced abitility do degrade starch and sugar (lowe levels of enzymes) have lower raise in blood glucose after a meal than those with normal expression of enzymes. We also want to examine whether those IBS patients with reduced enzyme levels have increased bowel symptom in relation to this meal.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 70
You may be able to join if
- Diagnosis of irritable bowel syndrome (IBS)
- Gene testing has been conducted regarding genes regulating the production of sucrase-isomaltase ensymes in previous dietary interventions using the...
You likely can't join if
- Diagnosis of inflammatory bowel disease, celiac disease, bile salt malabsorption, gastroenteritis or enteric dysmotility
- Severe food allergy
- Serious heart-, lung-, cardiovascular-, malignant- or mental illness
- Ongoing eating disorder
- Pregnancy
- Recent major gastrointestinal surgery
See the full eligibility criteria
- Diagnosis of irritable bowel syndrome (IBS)
- Gene testing has been conducted regarding genes regulating the production of sucrase-isomaltase ensymes in previous dietary interventions using the starch- and sucrose reduced diet (SSRD) or multi-center study.
- Diagnosis of inflammatory bowel disease, celiac disease, bile salt malabsorption, gastroenteritis or enteric dysmotility
- Severe food allergy
- Serious heart-, lung-, cardiovascular-, malignant- or mental illness
- Ongoing eating disorder
- Pregnancy
- Recent major gastrointestinal surgery
- Alcohol and/or drug addiction
The study team makes the final eligibility decision.
Where it's taking place
- Malmö, Skåne County, Sweden
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 70 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Malmö, Skåne County, Sweden. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.